Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome
- PMID: 28791334
- PMCID: PMC5547197
- DOI: 10.1523/ENEURO.0178-17.2017
Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome
Abstract
Considerable prior work suggests basal ganglia dysfunction in Tourette syndrome (TS). Analysis of a small number of postmortem specimens suggests deficits of some striatal interneuron populations, including striatal cholinergic interneurons. To assess the integrity of striatal cholinergic interneurons in TS, we used [18F]FEOBV positron emission tomography (PET) to quantify striatal vesicular acetylcholine transporter (VAChT) expression, a measure of cholinergic terminal density, in human TS and control subjects. We found no evidence of striatal cholinergic deficits. Discrepant imaging and postmortem analysis results may reflect agonal or postmortem changes, medication effects, or significant disease heterogeneity.
Keywords: Acetylcholine; Striatum; Tourette Syndrome; VChAT.
Figures

References
-
- Bowen DM, Smith CB, White P, Davison AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99:459–496. - PubMed
-
- Cubo E, Fernández Jaén A, Moreno C, Anaya B, González M, Kompoliti K (2008) Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study. Clin Ther 30:182–189. 10.1016/j.clinthera.2008.01.010 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical